Core Viewpoint - The company plans to invest up to RMB 60 million to establish a venture capital partnership focused on the brain science industry, aiming to enhance its investment and incubation capabilities [12][13][26]. Group 1: Company Overview - The company is Shanghai Beihigh New Co., Ltd., with stock codes 600604 and 900902 [5]. - The company has not undergone any changes in its controlling shareholder or actual controller [2][5]. Group 2: Financial Data - The company reported no new real estate reserve projects or new construction projects in the second quarter of 2025 [30]. - The company achieved a rental income of RMB 113 million in the second quarter of 2025, a decrease of 8.98% compared to the same period in 2024 [31]. Group 3: Investment Details - The company will participate as a limited partner in the Shanghai Delian Bojian Venture Capital Partnership, holding a 20% share [12][13]. - The total fund size is set at RMB 300 million, with a focus on early-stage and growth-stage investments in the brain science sector [20][22]. - The investment period is four years, followed by a four-year exit period, with a potential one-year extension [21][22]. Group 4: Governance and Decision-Making - The board of directors approved the investment proposal unanimously, with all seven directors present voting in favor [6][9][14]. - The investment does not constitute a related party transaction or a major asset restructuring as per regulatory definitions [14].

Core Viewpoint - The meeting in Shenzhen's Guangming District aims to promote high-quality development in the brain science and brain-machine engineering industry through collaboration among government, academia, and enterprises [1][8]. Group 1: Industry Development Initiatives - Guangming District is committed to creating an innovative hub for the brain science industry by optimizing policies, enhancing resource support, and deepening open cooperation [1][3]. - The district has established significant technological infrastructure for brain analysis and simulation, introduced the first specialized policy in the brain science sector, and set up a 1 billion yuan brain science industry fund [3][5]. - A 1.6 million yuan Shenzhen Blue Ocean Smart Brain Seed Fund has also been initiated to empower industry development [3]. Group 2: Collaborative Mechanisms - Guangming District has partnered with the Shenzhen Brain Science Society to create the "Guangming Brain Science Innovation Circle," which integrates researchers, clinical experts, industry specialists, and investment representatives into a collaborative framework [3][5]. - This collaboration aims to accelerate the establishment of a core cluster for the national brain science industry [3]. Group 3: Insights from Experts - Experts shared insights on the current state, technological frontiers, and future trends in the brain science industry, providing valuable references for Guangming District's strategic planning [5][8]. - Investment opportunities and challenges in the brain science sector were analyzed, emphasizing the integration of capital and technology to empower industry growth [5]. Group 4: Company Innovations - Companies like Shenzhen Delik Medical Electronics focus on AI development to enhance the functionality of neuroelectrophysiological products, aiming for domestic substitution in this field [6]. - Baying Technology (Shenzhen) aims to overcome traditional imaging technology limitations to provide reliable technical means for "nuclear medicine" research, facilitating early and precise diagnosis of brain metabolic diseases [6].